A bioprocessing tutorial on allogeneic and autologous therapies

Richard Grant, Invetech Global VP, Cell Therapy, has published a tutorial in Genetic Engineering & Biotechnology News.

In this tutorial, the key differences between allogeneic and autologous therapies are highlighted. These differences, which impact the planning and customization of facilities, must be understood if manufacturing is to proceed effectively.

Read the full article on GenEngNews.com.

Further Press Information

Alan Morris, Marketing Manager, Invetech, Alan.Morris@Invetech.us, + 61 3-9192-6194